Majbetegekért Alapítvány Foundation for Patients with Liver Disease

Email

villert@lamb.hu

Phone

T: +36 30-514-2956

Web

www.majbeteg.hu

Address

Albert Flórián út 5-7, Budapest H1097 H1097 Hungary
About Majbetegekért Alapítvány Foundation for Patients with Liver Disease

Main objectives of the Foundation for Patients with Liver Disease:

  • Promote higher standard of patients with chronic liver disease cared by the Szent László Hospital Clinic of Gastroenterology, Hepatology of care in line with European standards.
  • Helping the curative work of the liver units besides of Szent László Hospital.
  • Support for the new and the adequate current treatments are for the level of scientific clinical studies.
  • Promote research and treatment.
  • Promote investigation of liver transplant.
  • Supporting professional activity for prevention and medical care.
  • Promote early diagnosis, optimal treatment and care programs of liver disease.
  • Testing and application for of early diagnosis.
  • Gain experience for the modern possibilities of prevention.
  • Supporting the participation on relevant scientific congresses, symposia which are relevant of the objectives.
  • Cover the expenses necessary for research publication, in other – mainly on publications to patients – editing support.
  • Support grants for employees with outstanding activity (nurse assistant, doctor), includingl scholarships, study abroad, and the promotion of domestic and international conference participation.
  • Calls for proposals in the field of hepatology.
  • Financial supporting the publications, documents, lectures about patient's' health promoting, information.
  • Improving conditions in the hospital and ambulatory care.
  • Purchase of equipment and instruments.
  • Outsourcing equipments owned by the Foundation and ensure proper use of them.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close